Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rash
- 1 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (11) , 1566-1568
- https://doi.org/10.1097/00002030-200207260-00020
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Gender difference in ifosfamide metabolism by human liver microsomesEuropean Journal of Drug Metabolism and Pharmacokinetics, 2001
- Sex Differences in Nevirapine RashClinical Infectious Diseases, 2001
- Frequency of Cutaneous Reactions on Rechallenge with Nevirapine and DelavirdineAnnals of Pharmacotherapy, 2000
- Toxicidad asociada a efavirenz en personas infectadas por el VIH incluidas en el programa de acceso expandidoMedicina Clinica, 2000
- Gender Differences in Adverse Drug ReactionsThe Journal of Clinical Pharmacology, 1998
- High incidence of nevirapine-associated rash in HIV-infected ChineseAIDS, 1998
- Drug Evaluations Anti-infectives: Nevirapine: A review of its development, pharmacological profile and potential for clinical useExpert Opinion on Investigational Drugs, 1996
- Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 InfectionAnnals of Internal Medicine, 1996